Pancreatic Cancer News
News on Pancreatic Cancer continually updated from thousands of sources around the net.
Are you smarter than a 7th grade civics student?
Should polygamy be legal among consenting adults?
Engineered peptide drugs that simultaneously target two hormone receptors have historically attracted interest among scientists hoping to create new treatments for diabetes.
That was the message from Southampton surgeon Tim Underwood as he revealed his mission to tackle oesophageal cancer to one Hampshire MP.
On Tuesday, shares OncoMed Pharmaceuticals, Inc. catapulted nearly 100 percent to surpass the closing price from their IPO day back in July on news that the Redwood City, California -based drug maker had agreed with Celgene Corp. to jointly develop and commercialize up to six anti-cancer stem cell product candidates in the OncoMed pipeline.
Flotillin-1 and flotillin-2 are two homologous and ubiquitously expressed proteins that are involved in signal transduction and membrane trafficking.
OncoMed Pharmaceuticals, Inc. , a clinical-stage company developing novel therapeutics that target cancer stem cells , or tumor-initiating cells, today announced that it has started a Phase 1b clinical trial of its first-in-class Wnt-pathway-targeting antibody vantictumab in combination with nab-paclitaxel and gemcitabine in patients with Stage IV ... (more)
AndrA© Schiffrin, who died on December 1 of pancreatic cancer at age 78, made a lasting impression as longtime managing director of publishing at Pantheon Books, followed by his co-founding The New Press, a not-for-profit.
When Erin Joynt suffered stomach pain, she wrote it off as a possible stomach ulcer.
Muir-Torre syndrome is a rare disorder characterized by the presence of at least one sebaceous gland neoplasm and at least one visceral malignancy.
A potential drug therapy for Lou Gehrig's disease and a new treatment for pancreatic cancer were among the four promising technologies picked to receive a total of $600,000 in funding support through the University City Science Center's QED Proof-of-Concept Program.
With all of the recent activity in biotechnology stocks, it can be easy to forget about a small-cap stock that hasn't released as much news as some its peers.
For Emily Bennett Taylor, it started with a nagging cough. Her doctor first diagnosed her with bronchitis.
UOW project leader Dr Danielle Skropeta and Associate Professor Marie Ranson with Illawarra Cancer Carers volunteers Audrey Walsh, Sue Maidman and Jean Fleming.
Immunomedics, Inc. , a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the Company will present at the Oppenheimer 24th Annual Healthcare Conference on Tuesday, December 10th at 10:20 a.m. Eastern ... (more)
Doctors in hospitals around the world should be leaning in to hear the results of this study.
Nuvilex Accelerates Development of Treatments for Cancer and Diabetes With New Corporate Management Structure SILVER SPRING, Md., Nov. 25, 2013 -- Nuvilex, Inc. , a biotech company developing therapies for cancer, diabetes and other diseases based upon its live-cell encapsulation platform, today announced that Kenneth L. Waggoner, Esq.